Announcements Trials
Browse Landscape

Status

Completed 17Withdrawn 3Unknown 2Recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Observational 2

Sponsor

Cancer Type

Breast 3Other hematologic neoplasm 2Thoracic 1CNS 1

Conditions

Leukemia, Myeloid, Acute 1Leukemia 1

Interventions

Cytarabine 102Cyclophosphamide 74fludarabine 45Idarubicin 39Decitabine 36Etoposide 35Azacitidine 34Methotrexate 31Daunorubicin 30Vincristine 28Dexamethasone 27venetoclax 25Busulfan 24Imatinib Mesylate 23Radiotherapy 20Mercaptopurine 20Granulocyte Colony-Stimulating Factor 20Dasatinib 19Peripheral Blood Stem Cell Transplantation 18Mitoxantrone 17Doxorubicin 17Immunotherapy, Adoptive 16Rituximab 15Asparaginase 15Tretinoin 14Cladribine 14fludarabine phosphate 13Prednisone 13Prednisolone 13Melphalan 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × In Situ Hybridization, Fluorescence × Other hematologic neoplasm × Clear all
NCT04215822 2020-01-03

PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia

Assiut University

Unknown
80 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01653613 2013-07-10

Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia

National Cancer Institute (NCI)

Unknown
400 enrolled
Other hematologic neoplasm

Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡